临床前缺血性中风多中心试验 (PRISM) 集体声明:新时代的机遇,挑战和建议
Cenk Ayata1, Philip M Bath2, Anna M Planas3
1Department of Neurology, Massachusetts General Hospital, Boston (C.A.).
Stroke
|September 11, 2025
概括
多中心临床前随机对照试验 (mpRCTs) 通过模仿临床试验来推进中风研究. 这些严格的研究旨在弥合翻译差距,提高临床前发现临床疗效的可靠性.
科学领域:
- 神经科学是一个神经科学.
- 翻译医学是一种翻译医学.
- 临床试验 临床试验
背景情况:
- 临床前中风研究正在努力解决翻译差距,动物研究结果无法可靠地预测临床疗效.
- 该领域正在转向更严格的多中心临床前随机对照试验 (mpRCTs),以提高可翻译性.
研究的目的:
- 为设计和执行严格的多中心临床前随机对照试验 (mpRCTs) 提供专家指导.
- 为了解决实施中风研究mpRCTs的关键考虑和挑战.
主要方法:
- 参与mpRCTs的研究人员的专家共识和集体声明.
- 讨论关键组成部分,包括研究设计,统计考虑和基础设施.
主要成果:
- mpRCT提供了更大的样本大小,强大的统计设计和标准化的协议,但需要平衡标准化与异质性.
- 关键的挑战包括选择合适的中风模型,结果测量和管理网络基础设施.
- 机器学习的整合,共同的数据元素和数据共享对于mpRCT的效率至关重要.
结论:
- mpRCTs对提高临床前中风研究的可靠性和可翻译性具有显著的希望.
- 类似于临床试验平台的mpRCT平台的开发可以促进持续治疗评估.
- 为mpRCTs建立普遍接受的原则对于中风研究的未来至关重要.
相关概念视频
Ischemic Heart Disease: Overview
3.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Aneurysm II: Clinical Manifestations and Diagnostic Studies
308
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
308
Acute Coronary Syndrome III: Diagnostic Studies
219
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
219
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220


